Browse by Title

30 results found

Type here to filter the list

S
SACRAL CHORDOMA: A RANDOMIZED AND OBSERVATIONAL STUDY ON SURGERY VS DEFINITIVE RADIOTHERAPY IN PRIMARY LOCALIZED DISEASE (SACRO): INTERIM ANALYSIS (Paper 16)
Favorite

Stefano Radaelli, MD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2452521###Author###Dr.###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Author: Stefano Radaelli, MD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### he/him/his @@@ Maria Rosaria Fiore, M.D. – Fondazione CNAO - Centro Nazionale di Adroterapia Oncologica, Pavia, Italy ### 2453241###Co-Author###Dr.###Fondazione CNAO - Centro Nazionale di Adroterapia Oncologica, Pavia, Italy###
Co-Author: Maria Rosaria Fiore, M.D. – Fondazione CNAO - Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
### @@@ Maria Grazia Petrongari, M.D. – IRCCS - Istituto Nazionale Tumori Regina Elena,Rome , Italy ### 2453242###Co-Author###Prof.###IRCCS - Istituto Nazionale Tumori Regina Elena,Rome , Italy###
Co-Author: Maria Grazia Petrongari, M.D. – IRCCS - Istituto Nazionale Tumori Regina Elena,Rome , Italy
### @@@ Alessandro Gasbarrini, M.D. – IRCCS Istituto Ortopedico Rizzoli; Bologna, Italy ### 2453243###Co-Author###Prof.###IRCCS Istituto Ortopedico Rizzoli; Bologna, Italy###
Co-Author: Alessandro Gasbarrini, M.D. – IRCCS Istituto Ortopedico Rizzoli; Bologna, Italy
### @@@ Øyvind Bruland, M.D. – slo University Hospital - Norwegian Radium Hospital, Oslo, Norway ### 2453244###Co-Author######slo University Hospital - Norwegian Radium Hospital, Oslo, Norway###
Co-Author: Øyvind Bruland, M.D. – slo University Hospital - Norwegian Radium Hospital, Oslo, Norway
### @@@ Maria Pilar Sancho Marquez, MD – Hospital Universitario Virgen del Rocio ### 2452467###Co-Author######Hospital Universitario Virgen del Rocio###
Co-Author: Maria Pilar Sancho Marquez, MD – Hospital Universitario Virgen del Rocio
### @@@ Jendrik Hardes, M.D. – Klinik für Tumororthopädie - Universitätsklinikum Essen, Essen, Germany ### 2453245###Co-Author###Prof.###Klinik für Tumororthopädie - Universitätsklinikum Essen, Essen, Germany###
Co-Author: Jendrik Hardes, M.D. – Klinik für Tumororthopädie - Universitätsklinikum Essen, Essen, Germany
### @@@ Susanne Scheipl, MD, PhD (she/her/hers) – Univ. Klinik für Orthopädie und Traumatologie Medizinische Universität Graz, Graz, Austria ### 2453246###Co-Author###Dr###Univ. Klinik für Orthopädie und Traumatologie Medizinische Universität Graz, Graz, Austria###
Co-Author: Susanne Scheipl, MD, PhD (she/her/hers) – Univ. Klinik für Orthopädie und Traumatologie Medizinische Universität Graz, Graz, Austria
### she/her/hers @@@ Beate Timmermann, M.D. – Westdeutsches Protonentherapiezentrum Essen (WPE), Essen, Germany ### 2453247###Co-Author###Prof.###Westdeutsches Protonentherapiezentrum Essen (WPE), Essen, Germany###
Co-Author: Beate Timmermann, M.D. – Westdeutsches Protonentherapiezentrum Essen (WPE), Essen, Germany
### @@@ Toru Akiyama, M.D. – Saitama Medical Center, Saitama, Japan ### 2453248###Co-Author###Prof.###Saitama Medical Center, Saitama, Japan###
Co-Author: Toru Akiyama, M.D. – Saitama Medical Center, Saitama, Japan
### @@@ Ferdinando CM Cananzi, MD – IRCCS Humanitas Research Hospital ### 2453249###Co-Author######IRCCS Humanitas Research Hospital###
Co-Author: Ferdinando CM Cananzi, MD – IRCCS Humanitas Research Hospital
### @@@ Davide Maria Donati, M.D. – IRCCS Istituto Ortopedico Rizzoli; Bologna, Italy ### 2453250###Co-Author###Prof.###IRCCS Istituto Ortopedico Rizzoli; Bologna, Italy###
Co-Author: Davide Maria Donati, M.D. – IRCCS Istituto Ortopedico Rizzoli; Bologna, Italy
### @@@ Lorenzo Andreani, M.D. – Universita' di Pisa - Azienda Ospedaliera Universitaria Pisana, Pisa, Italy ### 2453251###Co-Author###Dr.###Universita' di Pisa - Azienda Ospedaliera Universitaria Pisana, Pisa, Italy###
Co-Author: Lorenzo Andreani, M.D. – Universita' di Pisa - Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
### @@@ Josè Manuel Asencio, M.D. – Hospital Universitario Gregorio Marañón, Madrid, Spain ### 2453252###Co-Author###Prof.###Hospital Universitario Gregorio Marañón, Madrid, Spain###
Co-Author: Josè Manuel Asencio, M.D. – Hospital Universitario Gregorio Marañón, Madrid, Spain
### @@@ Ramona Verges Capdevila, M.D, PhD – Hospital Val D’Hebron, Barcelona, Spain. ### 2453253###Co-Author###Dr.###Hospital Val D’Hebron, Barcelona, Spain.###
Co-Author: Ramona Verges Capdevila, M.D, PhD – Hospital Val D’Hebron, Barcelona, Spain.
### @@@ Alessandro Luzzati, M.D. – IRCCS, Istiuto Ortopedico Galeazzi ### 2453254###Co-Author###Dr.###IRCCS, Istiuto Ortopedico Galeazzi###
Co-Author: Alessandro Luzzati, M.D. – IRCCS, Istiuto Ortopedico Galeazzi
### @@@ Viviana Appolloni, PhD (she/her/hers) – Italian Sarcoma Group ETS, Italy ### 2453255###Co-Author###Clinical Research Coordinator###Italian Sarcoma Group ETS, Italy###
Co-Author: Viviana Appolloni, PhD (she/her/hers) – Italian Sarcoma Group ETS, Italy
### she/her/hers @@@ Gianluca Ignazzi (he/him/his) – Italian Sarcoma Group ETS, Italy ### 2453256###Co-Author###Clinical Research Coordinator###Italian Sarcoma Group ETS, Italy###
Co-Author: Gianluca Ignazzi (he/him/his) – Italian Sarcoma Group ETS, Italy
### he/him/his @@@ Daniela Salvatore, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan ### 2452482###Co-Author###Clinical Research Coordinator###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan###
Co-Author: Daniela Salvatore, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
### @@@ Matteo Carotenuto – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2453257###Co-Author###Clinical Research Coordinator###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Co-Author: Matteo Carotenuto – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### @@@ Rosalba Miceli, PhD (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2452522###Co-Author###Head of the Biostatistics for Clinical Research Unit###Fondazione IRCCS Istituto Nazionale dei Tumori###
Co-Author: Rosalba Miceli, PhD (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori
### she/her/hers @@@ Silvia Stacchiotti, MD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2452469###Co-Author###Medical Oncologist###Fondazione IRCCS Istituto Nazionale dei Tumori###
Co-Author: Silvia Stacchiotti, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Piero Fossati, M.D. – MedAustron Ion Therapy Centre, Graz, Austria ### 2453258###Co-Author###Dr.###MedAustron Ion Therapy Centre, Graz, Austria###
Co-Author: Piero Fossati, M.D. – MedAustron Ion Therapy Centre, Graz, Austria
### @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2452499###Co-Author###Chief of Sarcoma Service and Chair of the Department of Surgery###Fondazione IRCCS Istituto Nazionale dei Tumori###
Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori
### he/him/his Paper 16
SAFETY, EFFICACY, AND PATIENT-REPORTED OUTCOMES WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED PRIOR ANTI-COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 STUDY (Paper 106)
Favorite

Andrew J. Wagner, MD, PhD – Dana-Farber Cancer Institute ### 2452555###Author###MD, PhD###Dana-Farber Cancer Institute###
Author: Andrew J. Wagner, MD, PhD – Dana-Farber Cancer Institute
### @@@ Gina D’Amato, MD – Sylvester Comprehensive Cancer Center, University of Miami ### 2452616###Co-Author######Sylvester Comprehensive Cancer Center, University of Miami###
Co-Author: Gina D’Amato, MD – Sylvester Comprehensive Cancer Center, University of Miami
### @@@ Kristen N. Ganjoo, MD – Stanford Comprehensive Cancer Center ### 2452472###Co-Author######Stanford Comprehensive Cancer Center###
Co-Author: Kristen N. Ganjoo, MD – Stanford Comprehensive Cancer Center
### @@@ Silvia Stacchiotti, MD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2452469###Co-Author###Medical Oncologist###Fondazione IRCCS Istituto Nazionale dei Tumori###
Co-Author: Silvia Stacchiotti, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Hans Gelderblom, MD, PhD – Leiden University Medical Center ### 2452755###Co-Author######Leiden University Medical Center###
Co-Author: Hans Gelderblom, MD, PhD – Leiden University Medical Center
### @@@ Christopher W. Ryan, MD – OHSU Knight Cancer Institute ### 2452833###Co-Author######OHSU Knight Cancer Institute###
Co-Author: Christopher W. Ryan, MD – OHSU Knight Cancer Institute
### @@@ Emanuela Palmerini, MD, PhD – IRCCS Istituto Ortopedico Rizzoli ### 2452804###Co-Author###Consultant Medical oncologist###IRCCS Istituto Ortopedico Rizzoli###
Co-Author: Emanuela Palmerini, MD, PhD – IRCCS Istituto Ortopedico Rizzoli
### @@@ Vinod Ravi, MD, MBA – The University of Texas MD Anderson Cancer Center ### 2452409###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Vinod Ravi, MD, MBA – The University of Texas MD Anderson Cancer Center
### @@@ Ramy Saleh, MD – McGill University Health Centre Research Institute ### 2452834###Co-Author######McGill University Health Centre Research Institute###
Co-Author: Ramy Saleh, MD – McGill University Health Centre Research Institute
### @@@ Axel Le Cesne, MD – Gustave Roussy ### 2452748###Co-Author######Gustave Roussy###
Co-Author: Axel Le Cesne, MD – Gustave Roussy
### @@@ Nicholas M. Bernthal, MD – University of California Los Angeles ### 2452744###Co-Author######University of California Los Angeles###
Co-Author: Nicholas M. Bernthal, MD – University of California Los Angeles
### @@@ Michiel AJ van de Sande, Professor (he/him/his) – Princes Maxima Center for pediatric oncology and LUMC leiden ### 2452941###Co-Author###Professor in Orthopedic Oncology###Princes Maxima Center for pediatric oncology and LUMC leiden ###
Co-Author: Michiel AJ van de Sande, Professor (he/him/his) – Princes Maxima Center for pediatric oncology and LUMC leiden
### he/him/his @@@ Supraja Narasimhan, PhD (she/her/hers) – Deciphera Pharmaceuticals, A member of ONO Pharma ### 2452835###Co-Author###Associate Director, Clinical Scientist###Deciphera Pharmaceuticals, A member of ONO Pharma###
Co-Author: Supraja Narasimhan, PhD (she/her/hers) – Deciphera Pharmaceuticals, A member of ONO Pharma
### she/her/hers @@@ Brooke Harrow, PhD – Deciphera Pharmaceuticals, LLC ### 2452751###Co-Author######Deciphera Pharmaceuticals, LLC###
Co-Author: Brooke Harrow, PhD – Deciphera Pharmaceuticals, LLC
### @@@ Amanda Saunders, DO – Deciphera Pharmaceuticals, LLC ### 2452836###Co-Author######Deciphera Pharmaceuticals, LLC###
Co-Author: Amanda Saunders, DO – Deciphera Pharmaceuticals, LLC
### @@@ Rodrigo Ruiz-Soto, MD – Deciphera Pharmaceuticals, LLC ### 2452753###Co-Author######Deciphera Pharmaceuticals, LLC###
Co-Author: Rodrigo Ruiz-Soto, MD – Deciphera Pharmaceuticals, LLC
### @@@ Matthew L. Sherman, MD – Deciphera Pharmaceuticals, LLC ### 2452754###Co-Author######Deciphera Pharmaceuticals, LLC###
Co-Author: Matthew L. Sherman, MD – Deciphera Pharmaceuticals, LLC
### @@@ William D. Tap, MD – Department of Medicine, Memorial Sloan Kettering Cancer Center Department of Medicine, Weill Cornell Medical College ### 2452547###Co-Author######Department of Medicine, Memorial Sloan Kettering Cancer Center Department of Medicine, Weill Cornell Medical College###
Co-Author: William D. Tap, MD – Department of Medicine, Memorial Sloan Kettering Cancer Center Department of Medicine, Weill Cornell Medical College
### Paper 106
Sarcoma of the Year: Dedifferentiated Liposarcoma
Favorite

Roberta Sanfilippo, MD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2453087###Moderator###MD###Fondazione IRCCS Istituto Nazionale dei Tumori###
Moderator: Roberta Sanfilippo, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Winan van Houdt, MD, PhD – Netherlands Cancer Institute ### 2452508###Moderator###Surgical Oncologist###Netherlands Cancer Institute###
Moderator: Winan van Houdt, MD, PhD – Netherlands Cancer Institute
###
SARCOSIGHT- A RANDOMISED CONTROLLED TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS STANDARD OF CARE (Paper 75)
Favorite

Kenneth Rankin, MBChB MD FRCS – North of England Bone and Soft Tissue Tumour Service ### 2452776###Author###Consultant Orthopaedic Oncology Surgeon###North of England Bone and Soft Tissue Tumour Service###
Author: Kenneth Rankin, MBChB MD FRCS – North of England Bone and Soft Tissue Tumour Service
### @@@ Marcus Brookes, MBBS, MRes, MRCS, PGCert – The Newcastle upon Tyne Hospitals NHS Foundation Trust ### 2452777###Co-Author###Academic Clinical Fellow in Plastic Surgery###The Newcastle upon Tyne Hospitals NHS Foundation Trust###
Co-Author: Marcus Brookes, MBBS, MRes, MRCS, PGCert – The Newcastle upon Tyne Hospitals NHS Foundation Trust
### @@@ Corey D. Chan, MBBS MRes – Newcastle University Centre for Cancer ### 2452778###Co-Author###NIHR Academic Clinical Fellow in Orthopaedic Surgery###Newcastle University Centre for Cancer###
Co-Author: Corey D. Chan, MBBS MRes – Newcastle University Centre for Cancer
### @@@ Craig Gerrand, MD – Royal National Orthopaedic Hospital, NHS England ### 2452779###Co-Author######Royal National Orthopaedic Hospital, NHS England###
Co-Author: Craig Gerrand, MD – Royal National Orthopaedic Hospital, NHS England
### @@@ Maniram Ragbir, FRCS – North of England Bone and Soft Tissue Tumour Service ### 2452780###Co-Author######North of England Bone and Soft Tissue Tumour Service###
Co-Author: Maniram Ragbir, FRCS – North of England Bone and Soft Tissue Tumour Service
### @@@ Alastair Burt, MD FRCPath – Newcastle University ### 2452781###Co-Author######Newcastle University###
Co-Author: Alastair Burt, MD FRCPath – Newcastle University
### Paper 75
SECOND MALIGNANT NEOPLASM FOLLOWING TREATMENT FOR NON-METASTATIC EWING SARCOMA IN PATIENTS ENROLLED ON FRONTLINE PHASE 3 CLINICAL TRIALS: A REPORT FROM CHILDREN'S ONCOLOGY GROUP (Paper 71)
Favorite

Susan Whiteway, MD – Department of Pediatrics, Uniformed Services University ### 2452964###Author###Associate Professor###Department of Pediatrics, Uniformed Services University ###
Author: Susan Whiteway, MD – Department of Pediatrics, Uniformed Services University
### @@@ Natalie DelRocco, PhD – Childrens Oncology Group ### 2452965###Co-Author######Childrens Oncology Group###
Co-Author: Natalie DelRocco, PhD – Childrens Oncology Group
### @@@ Ruxu Han, MS – Childrens Oncology Group ### 2452966###Co-Author######Childrens Oncology Group###
Co-Author: Ruxu Han, MS – Childrens Oncology Group
### @@@ Holcombe Grier, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center, ### 2452967###Co-Author######Dana-Farber/Boston Children's Cancer and Blood Disorders Center,###
Co-Author: Holcombe Grier, MD – Dana-Farber/Boston Children's Cancer and Blood Disorders Center,
### @@@ Patrick Leavey, MD – UT Southwestern/Simmons Cancer Center-Dallas ### 2452968###Co-Author######UT Southwestern/Simmons Cancer Center-Dallas###
Co-Author: Patrick Leavey, MD – UT Southwestern/Simmons Cancer Center-Dallas
### @@@ Damon Reed, MD – Memorial Sloan Kettering ### 2452899###Co-Author######Memorial Sloan Kettering###
Co-Author: Damon Reed, MD – Memorial Sloan Kettering
### @@@ Katherine A. Janeway, MD MMSc – Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School ### 2452449###Co-Author###Senior Physician###Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School###
Co-Author: Katherine A. Janeway, MD MMSc – Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School
### @@@ Mark Krailo, PhD – Childrens Oncology Group ### 2452969###Co-Author######Childrens Oncology Group###
Co-Author: Mark Krailo, PhD – Childrens Oncology Group
### @@@ Smita Bhatia, MD/MPH – Children's Hospital of Alabama ### 2452970###Co-Author######Children's Hospital of Alabama###
Co-Author: Smita Bhatia, MD/MPH – Children's Hospital of Alabama
### @@@ Leo Mascarenhas, MD, MS – Cedars-Sinai Medical Center, California, CA, USA ### 2452682###Co-Author######Cedars-Sinai Medical Center, California, CA, USA###
Co-Author: Leo Mascarenhas, MD, MS – Cedars-Sinai Medical Center, California, CA, USA
### Paper 71
SELECTIVE INTERNAL RADIATION THERAPY FOR SUCCINATE DEHYDROGENASE DEFICIENT GASTROINTESTINAL STROMAL TUMORS DEMONSTRATES ENCOURAGING DURABLE RESPONSE RATES: AN INTERNATIONAL MULTICENTER CASE SERIES (Paper 14)
Favorite

Zachary T. Berman, MD – Univeristy of California, San Diego ### 2452631###Author###Associate Clinical Professor###Univeristy of California, San Diego###
Author: Zachary T. Berman, MD – Univeristy of California, San Diego
### @@@ Peter Hohenberger, MD – Mannheim University ### 2452632###Co-Author######Mannheim University###
Co-Author: Peter Hohenberger, MD – Mannheim University
### @@@ Steven C. Rose, MD – University of California, San Diego ### 2452633###Co-Author######University of California, San Diego###
Co-Author: Steven C. Rose, MD – University of California, San Diego
### @@@ Ramesh Bulusu, MD – Cambridge University ### 2452634###Co-Author######Cambridge University###
Co-Author: Ramesh Bulusu, MD – Cambridge University
### @@@ Paul Fanta, M.D. – University of California, San Diego ### 2452544###Co-Author###Professor###University of California, San Diego###
Co-Author: Paul Fanta, M.D. – University of California, San Diego
### @@@ Jason K. Sicklick, M.D., FACS – University of California, San Diego ### 2452546###Co-Author###Professor/Principal Investigator###University of California, San Diego###
Co-Author: Jason K. Sicklick, M.D., FACS – University of California, San Diego
### Paper 14
Session 1: Fusion Driven Sarcomas
Favorite

Priya Chudasama, PhD – German Cancer Research Center ### 2453305###Moderator###Research Group Leader###German Cancer Research Center###
Moderator: Priya Chudasama, PhD – German Cancer Research Center
### @@@ Torsten Nielsen, MD, PhD – Department of Pathology, VGH ### 1430191###Moderator###Professor of Pathology###Department of Pathology, VGH###
Moderator: Torsten Nielsen, MD, PhD – Department of Pathology, VGH
###
Session 1: Tumor Heterogeneity & Resistance
Favorite

Anand G. Patel, MD, PhD (he/him/his) – St. Jude Children’s Research Hospital ### 2452938###Moderator###Assistant Member###St. Jude Children’s Research Hospital###
Moderator: Anand G. Patel, MD, PhD (he/him/his) – St. Jude Children’s Research Hospital
### he/him/his @@@ Everett J. Moding, MD, PhD (he/him/his) – Stanford University ### 2452664###Moderator###Assistant Professor###Stanford University###
Moderator: Everett J. Moding, MD, PhD (he/him/his) – Stanford University
### he/him/his
Session 10: Pediatric, Adolescent & Young Adult Sarcomas
Favorite

Viswatej Avutu, MD (he/him/his) – Memorial Sloan Kettering Cancer Center ### 2452957###Moderator###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Moderator: Viswatej Avutu, MD (he/him/his) – Memorial Sloan Kettering Cancer Center
### he/him/his @@@ Sapna Oberoi, MD, MSc – CancerCare Manitoba ### 2452837###Moderator###Assistant Professor###CancerCare Manitoba###
Moderator: Sapna Oberoi, MD, MSc – CancerCare Manitoba
###
Session 11: Trials in Progress/Late Breaking Trials
Favorite

Palma Dileo, MD (she/her/hers) – University College London Hospitals NHS Foundation Trust ### 2452985###Moderator###Consultant Medical Oncologist @###University College London Hospitals NHS Foundation Trust###
Moderator: Palma Dileo, MD (she/her/hers) – University College London Hospitals NHS Foundation Trust
### she/her/hers @@@ Steven I. Robinson, M.B.B.S. (he/him/his) – Mayo Clinic ### 2452688###Moderator###Associate Professor of Oncology###Mayo Clinic###
Moderator: Steven I. Robinson, M.B.B.S. (he/him/his) – Mayo Clinic
### he/him/his
Session 12: Immunology
Favorite

Breelyn A. Wilky, MD (she/her/hers) – University of Colorado School of Medicine ### 2452636###Moderator###Associate Professor###University of Colorado School of Medicine###
Moderator: Breelyn A. Wilky, MD (she/her/hers) – University of Colorado School of Medicine
### she/her/hers @@@ Ymera Pignochino, PhD (she/her/hers) – University of Turin, School of Medicine,Candiolo Cancer Institute, FPO-IRCCS ### 2104781###Moderator###Assistant Professor### University of Turin, School of Medicine,Candiolo Cancer Institute, FPO-IRCCS###
Moderator: Ymera Pignochino, PhD (she/her/hers) – University of Turin, School of Medicine,Candiolo Cancer Institute, FPO-IRCCS
### she/her/hers
Session 13: Creative and Inventive Approaches in Sarcoma Research
Favorite

John Mullinax, MD – Moffitt Cancer Center ### 2452505###Moderator###Associate Member###Moffitt Cancer Center###
Moderator: John Mullinax, MD – Moffitt Cancer Center
### @@@ Tom Wei-Wu Chen, MD PhD – National Taiwan University Hospital ### 2101854###Moderator###Attending Physician###National Taiwan University Hospital###
Moderator: Tom Wei-Wu Chen, MD PhD – National Taiwan University Hospital
###
Session 14: Diagnostic Approaches: Pathologic, Radiologic, and Molecular
Favorite

Behrang Amini, MD PhD – The University of Texas MD Anderson Cancer Center ### 2452420###Moderator###Professor###The University of Texas MD Anderson Cancer Center###
Moderator: Behrang Amini, MD PhD – The University of Texas MD Anderson Cancer Center
### @@@ Robin L. Jones, BSc, MB BS, MRCP, MD – Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research ### 2453100###Moderator###Professor###Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research###
Moderator: Robin L. Jones, BSc, MB BS, MRCP, MD – Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
###
Session 15: Desmoid Fibromatosis and TGCT
Favorite

Samuel Ford, PhD, FRCS – Queen Elizabeth Hospital ### 2452487###Moderator###Consultant Sarcoma Surgeon###Queen Elizabeth Hospital###
Moderator: Samuel Ford, PhD, FRCS – Queen Elizabeth Hospital
### @@@ Michiel AJ van de Sande, Professor (he/him/his) – Princes Maxima Center for pediatric oncology and LUMC leiden ### 2452941###Moderator###Professor in Orthopedic Oncology###Princes Maxima Center for pediatric oncology and LUMC leiden ###
Moderator: Michiel AJ van de Sande, Professor (he/him/his) – Princes Maxima Center for pediatric oncology and LUMC leiden
### he/him/his
Session 16: Health Services Research, Global Health, Advocacy, and Patient-Centered Outcomes
Favorite

Dorian Yarih García-Ortega, MD, MSc, PhD, FACS, FSSO (he/him/his) – Instituto Nacional de Cancerología (México) ### 1772191###Moderator###Surgical Oncologist###Instituto Nacional de Cancerología (México)###
Moderator: Dorian Yarih García-Ortega, MD, MSc, PhD, FACS, FSSO (he/him/his) – Instituto Nacional de Cancerología (México)
### he/him/his @@@ Winta T. Mehtsun, MD, MPH (she/her/hers) – University of California, San Diego ### 1772702###Moderator###Assistant Professor of Surgery###University of California, San Diego###
Moderator: Winta T. Mehtsun, MD, MPH (she/her/hers) – University of California, San Diego
### she/her/hers
Session 2: Complex Karyotype Sarcomas
Favorite

Judith Bovee – LUMC ### 1137174###Moderator###Prof. Dr.###LUMC###
Moderator: Judith Bovee – LUMC
### @@@ Rebecca A. Gladdy, MD, PhD – Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto ### 1430198###Moderator###Associate Professor###Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto###
Moderator: Rebecca A. Gladdy, MD, PhD – Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto
###
Session 2: GIST
Favorite

Lori Rink, PhD (she/her/hers) – Fox Chase Cancer Center ### 2103885###Moderator###Associate Professor###Fox Chase Cancer Center###
Moderator: Lori Rink, PhD (she/her/hers) – Fox Chase Cancer Center
### she/her/hers @@@ Patrick Schöffski, Prof Dr – Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven ### 2452850###Moderator###Head of Department General Medical Oncology###Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven###
Moderator: Patrick Schöffski, Prof Dr – Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven
###
Session 3: Bone Sarcomas
Favorite

Claudia M. Valverde Morales, MD, PhD – Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d´Hebrón Institute of Oncology ### 2453266###Moderator###Dr###Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d´Hebrón Institute of Oncology###
Moderator: Claudia M. Valverde Morales, MD, PhD – Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d´Hebrón Institute of Oncology
### @@@ Ravin Ratan, MD, MEd – University of Texas, MD Anderson Cancer Center, Department of Sarcoma Medical Oncology, Division of Cancer Medicine ### 2452408###Moderator###Associate Professor###University of Texas, MD Anderson Cancer Center, Department of Sarcoma Medical Oncology, Division of Cancer Medicine###
Moderator: Ravin Ratan, MD, MEd – University of Texas, MD Anderson Cancer Center, Department of Sarcoma Medical Oncology, Division of Cancer Medicine
###
Session 3: Spatial Transcriptomics & Tumor Microenvironment
Favorite

Joanna Przybyl, PhD (she/her/hers) – McGill University ### 2453147###Moderator###Assistant Professor###McGill University###
Moderator: Joanna Przybyl, PhD (she/her/hers) – McGill University
### she/her/hers @@@ Alejandro Sweet-Cordero, MD – University of California, San Francisco ### 1430804###Moderator###Professor###University of California, San Francisco###
Moderator: Alejandro Sweet-Cordero, MD – University of California, San Francisco
###
Session 4: Orthopedic Resection & Reconstruction
Favorite

Juan P. Zumarraga, MD, PhD (he/him/his) – Hospital Metropolitano (Quito - Ecuador) ### 2484251###Moderator###Orthopedic Surgeon / Orthopedic Oncologist###Hospital Metropolitano (Quito - Ecuador)###
Moderator: Juan P. Zumarraga, MD, PhD (he/him/his) – Hospital Metropolitano (Quito - Ecuador)
### he/him/his @@@ Rosanna Wustrack, MD – UCSF ### 1451870###Moderator###Associate Professor Clinical Orthopedic Surgery###UCSF###
Moderator: Rosanna Wustrack, MD – UCSF
###
Session 5: Preclinical Models and Clinical Translation
Favorite

Alice Soragni, PhD – University of California, Los Angeles ### 1772830###Moderator###Assistant Professor###University of California, Los Angeles###
Moderator: Alice Soragni, PhD – University of California, Los Angeles
### @@@ Elizabeth A. Stewart, MD (she/her/hers) – St. Jude Children's Research Hospital ### 2452593###Moderator###Associate Member, Solid Tumor Division###St. Jude Children's Research Hospital###
Moderator: Elizabeth A. Stewart, MD (she/her/hers) – St. Jude Children's Research Hospital
### she/her/hers
Session 6: Retroperitoneal and Abdominal Sarcomas
Favorite

Emily Keung, MD – MD Anderson Cancer Center ### 2452740###Moderator###Assistant Professor###MD Anderson Cancer Center###
Moderator: Emily Keung, MD – MD Anderson Cancer Center
### @@@ Dario Callegaro, MD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2452514###Moderator###Attending Surgical Oncologist###Fondazione IRCCS Istituto Nazionale dei Tumori###
Moderator: Dario Callegaro, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
###
Session 7: Radiation Oncology
Favorite

Angela M. Hong, MBBS, MMed, PhD – Royal Prince Alfred Hospital ### 2453020###Moderator###Radiation Oncologist###Royal Prince Alfred Hospital###
Moderator: Angela M. Hong, MBBS, MMed, PhD – Royal Prince Alfred Hospital
### @@@ Lisette Wiltink, MD PhD – The Leiden University Medical Center ### 1431077###Moderator###Dr###The Leiden University Medical Center###
Moderator: Lisette Wiltink, MD PhD – The Leiden University Medical Center
###
Session 8: Basic Science
Favorite

Janai Carr-Ascher, MD, PhD (she/her/hers) – University of California Davis ### 2102322###Moderator###Assistant Professor###University of California Davis###
Moderator: Janai Carr-Ascher, MD, PhD (she/her/hers) – University of California Davis
### she/her/hers @@@ Paul Huang, PhD – ICR ### 2453014###Moderator###Group Leader###ICR###
Moderator: Paul Huang, PhD – ICR
###
Session 9: Structural and Functional Omics
Favorite

Sandro Pasquali, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2452494###Moderator######Fondazione IRCCS Istituto Nazionale dei Tumori###
Moderator: Sandro Pasquali, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 2452471###Moderator###Professor of Medicine###Washington University in St. Louis###
Moderator: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
###
SINGLE CELL ATLAS OF WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA SUGGESTS UNDERLYING EPIGENETIC PROGRAMS DRIVING TRANSTION BETWEEN WELL- AND DE-DIFFERENTIATED STATES (Paper 46)
Favorite

Veena Kochat, PhD – MD Anderson Cancer Center ### 2452558###Co-Author######MD Anderson Cancer Center###
Co-Author: Veena Kochat, PhD – MD Anderson Cancer Center
### @@@ Emre Arslan, PhD – MD Anderson Cancer Center ### 2452557###Co-Author######MD Anderson Cancer Center###
Co-Author: Emre Arslan, PhD – MD Anderson Cancer Center
### @@@ Ryan A. Denu, MD, PhD (he/him/his) – MD Anderson Cancer Center ### 2452792###Author###Medical Oncology Fellow###MD Anderson Cancer Center###
Author: Ryan A. Denu, MD, PhD (he/him/his) – MD Anderson Cancer Center
### he/him/his @@@ Danh D. Truong, PhD (he/him/his) – MD Anderson Cancer Center ### 2452556###Co-Author###Instructor###MD Anderson Cancer Center###
Co-Author: Danh D. Truong, PhD (he/him/his) – MD Anderson Cancer Center
### he/him/his @@@ Corey Weistuch, PhD (he/him/his) – Memorial Sloan Kettering Cancer Center ### 2452798###Co-Author###Postdoctoral Research Scholar###Memorial Sloan Kettering Cancer Center###
Co-Author: Corey Weistuch, PhD (he/him/his) – Memorial Sloan Kettering Cancer Center
### he/him/his @@@ Margarita Divenko, n/a – Baylor College of Medicine ### 2452799###Co-Author######Baylor College of Medicine###
Co-Author: Margarita Divenko, n/a – Baylor College of Medicine
### @@@ Manrong Wu, n/a – The University of Texas MD Anderson Cancer Center ### 2452800###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Manrong Wu, n/a – The University of Texas MD Anderson Cancer Center
### @@@ William Padron, n/a – The University of Texas MD Anderson Cancer Center ### 2452794###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: William Padron, n/a – The University of Texas MD Anderson Cancer Center
### @@@ Davis Ingram, n/a – MD Anderson Cancer Center ### 2452563###Co-Author######MD Anderson Cancer Center###
Co-Author: Davis Ingram, n/a – MD Anderson Cancer Center
### @@@ Khalida Wani, PhD – The University of Texas MD Anderson Cancer Center ### 2452801###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Khalida Wani, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Christina Roland, MD, MS (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2452741###Co-Author###Associate Professor###The University of Texas MD Anderson Cancer Center###
Co-Author: Christina Roland, MD, MS (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Emily Keung, MD – MD Anderson Cancer Center ### 2452740###Co-Author###Assistant Professor###MD Anderson Cancer Center###
Co-Author: Emily Keung, MD – MD Anderson Cancer Center
### @@@ Elise Nassif Haddad, MD – The University of Texas MD Anderson Cancer Center ### 2452797###Co-Author###Assistant Professor###The University of Texas MD Anderson Cancer Center###
Co-Author: Elise Nassif Haddad, MD – The University of Texas MD Anderson Cancer Center
### @@@ Alexander Lazar, MD PhD – MD Anderson Cancer Center ### 2452571###Co-Author######MD Anderson Cancer Center###
Co-Author: Alexander Lazar, MD PhD – MD Anderson Cancer Center
### @@@ Joseph Ludwig, MD – MD Anderson Cancer Center ### 2452574###Co-Author######MD Anderson Cancer Center###
Co-Author: Joseph Ludwig, MD – MD Anderson Cancer Center
### @@@ Neeta Somaiah, MD – The University of Texas MD Anderson Cancer Center ### 2452406###Co-Author###Professor & Deputy ChairSarcoma Medical Oncology###The University of Texas MD Anderson Cancer Center###
Co-Author: Neeta Somaiah, MD – The University of Texas MD Anderson Cancer Center
### @@@ Kunal Rai, PhD – MD Anderson Cancer Center ### 2452572###Co-Author######MD Anderson Cancer Center###
Co-Author: Kunal Rai, PhD – MD Anderson Cancer Center
### Paper 46
SINGLE CELL TRANSCRIPTOMIC PROFILING IDENTIFIES TUMOR-ACQUIRED AND THERAPY-RESISTANT CELL STATES IN PEDIATRIC RHABDOMYOSARCOMA (Paper 02)
Favorite

Sara G. Danielli, PhD (she/her/hers) – Dana-Farber Cancer Institute / Harvard Medical School ### 2452932###Young Investigator Award Winner###Research Fellow###Dana-Farber Cancer Institute / Harvard Medical School###
Young Investigator Award Winner: Sara G. Danielli, PhD (she/her/hers) – Dana-Farber Cancer Institute / Harvard Medical School
### she/her/hers @@@ Yun Wei, PhD – Massachusetts General Research Institute ### 2452933###Co-Author######Massachusetts General Research Institute###
Co-Author: Yun Wei, PhD – Massachusetts General Research Institute
### @@@ Michael A. Dyer, PhD – St. Jude Children’s Research Hospital ### 2452934###Co-Author######St. Jude Children’s Research Hospital###
Co-Author: Michael A. Dyer, PhD – St. Jude Children’s Research Hospital
### @@@ Elizabeth A. Stewart, MD (she/her/hers) – St. Jude Children's Research Hospital ### 2452593###Co-Author###Associate Member, Solid Tumor Division###St. Jude Children's Research Hospital###
Co-Author: Elizabeth A. Stewart, MD (she/her/hers) – St. Jude Children's Research Hospital
### she/her/hers @@@ Heather Sheppard, PhD – St. Jude Children’s Research Hospital ### 2452935###Co-Author######St. Jude Children’s Research Hospital###
Co-Author: Heather Sheppard, PhD – St. Jude Children’s Research Hospital
### @@@ Marco Wachtel, PhD – University Children's Hospital of Zürich ### 2452936###Co-Author######University Children's Hospital of Zürich###
Co-Author: Marco Wachtel, PhD – University Children's Hospital of Zürich
### @@@ Beat W. Schäfer, PhD – University Children's Hospital of Zürich ### 2452937###Co-Author######University Children's Hospital of Zürich###
Co-Author: Beat W. Schäfer, PhD – University Children's Hospital of Zürich
### @@@ Anand G. Patel, MD, PhD (he/him/his) – St. Jude Children’s Research Hospital ### 2452938###Co-Author###Assistant Member###St. Jude Children’s Research Hospital###
Co-Author: Anand G. Patel, MD, PhD (he/him/his) – St. Jude Children’s Research Hospital
### he/him/his @@@ David M. Langenau, PhD (he/him/his) – Massachusetts General Research Institute ### 2452939###Co-Author###Professor of Pathology###Massachusetts General Research Institute###
Co-Author: David M. Langenau, PhD (he/him/his) – Massachusetts General Research Institute
### he/him/his Paper 02
SPATIAL TRANSCRIPTOMICS OF EWING SARCOMA: EVOLUTION OF TUMOR MICROENVIRONMENT ASSOCIATED EXTRACELLULAR MATRIX FROM LOCALIZED TO METASTASIS-ASSOCIATED PRIMARY TUMORS
Favorite

Christopher Kuo, M.D (he/him/his) – Children's Hospital Los Angeles ### 1772452###Author###Clinical Instructor of Pediatrics###Children's Hospital Los Angeles###
Author: Christopher Kuo, M.D (he/him/his) – Children's Hospital Los Angeles
### he/him/his @@@ Krinio Giannikou, M.Sc., Ph.D. – Children's Hospital Los Angeles ### 2460944###Co-Author######Children's Hospital Los Angeles###
Co-Author: Krinio Giannikou, M.Sc., Ph.D. – Children's Hospital Los Angeles
### @@@ Nuoya Wang, n/a – Yale School of Medicine ### 2460945###Co-Author######Yale School of Medicine###
Co-Author: Nuoya Wang, n/a – Yale School of Medicine
### @@@ Mikako Warren, MD – Children's Hospital Los Angeles ### 2103753###Co-Author######Children's Hospital Los Angeles###
Co-Author: Mikako Warren, MD – Children's Hospital Los Angeles
### @@@ Andrew Goodspeed, PhD – University of Colorado Cancer Center ### 2460946###Co-Author######University of Colorado Cancer Center###
Co-Author: Andrew Goodspeed, PhD – University of Colorado Cancer Center
### @@@ Masanori Hayashi, N/A, MD – University of Colorado Cancer Center ### 1771655###Co-Author######University of Colorado Cancer Center###
Co-Author: Masanori Hayashi, N/A, MD – University of Colorado Cancer Center
### @@@ Micha Sam Brickman Raredon, MD, PhD – Yale School of Medicine ### 2460947###Co-Author######Yale School of Medicine###
Co-Author: Micha Sam Brickman Raredon, MD, PhD – Yale School of Medicine
### @@@ James F. Amatruda, MD, PhD – Children's Hospital Los Angeles ### 2453441### Co-Author###Director, Cancer and Blood Disease Institute###Children's Hospital Los Angeles###
Co-Author: James F. Amatruda, MD, PhD – Children's Hospital Los Angeles
###
SPATIAL TRANSCRIPTOMICS REVEALS UNIQUE TRANSCRIPTIONAL AND IMMUNE PROFILES OF PRIMARY UNDIFFERENTIATED PLEOMORPHIC, EPITHELIOID, AND CLEAR CELL SARCOMAS AND PAIRED LYMPH NODE METASTASES (Paper 07)
Favorite

Ian W. Folkert, MD, PhD – The University of Texas MD Anderson Cancer Center ### 2452944###Author###Fellow###The University of Texas MD Anderson Cancer Center###
Author: Ian W. Folkert, MD, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Brenda Melendez, PhD – The University of Texas MD Anderson Cancer Center ### 2452945###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Brenda Melendez, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Russell G. Witt, MD – The University of Virginia ### 2452946###Co-Author######The University of Virginia###
Co-Author: Russell G. Witt, MD – The University of Virginia
### @@@ Rossana Lazcano, MD – The University of Texas MD Anderson Cancer Center ### 2452947###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Rossana Lazcano, MD – The University of Texas MD Anderson Cancer Center
### @@@ Bharat B. Singh, n/a – The University of Texas MD Anderson Cancer Center ### 2452948###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Bharat B. Singh, n/a – The University of Texas MD Anderson Cancer Center
### @@@ Brandon Cope, MD – Keesler Air Force Base ### 2452949###Co-Author######Keesler Air Force Base###
Co-Author: Brandon Cope, MD – Keesler Air Force Base
### @@@ Amblessed Onuma, MD – The University of Texas MD Anderson Cancer Center ### 2452950###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Amblessed Onuma, MD – The University of Texas MD Anderson Cancer Center
### @@@ Varshini Arunkumar, n/a – The University of Texas MD Anderson Cancer Center ### 2452951###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Varshini Arunkumar, n/a – The University of Texas MD Anderson Cancer Center
### @@@ Lon Fong, PhD – The University of Texas MD Anderson Cancer Center ### 2452952###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Lon Fong, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Rohini Morey, n/a – The University of Texas MD Anderson Cancer Center - ### 2452953###Co-Author######The University of Texas MD Anderson Cancer Center -###
Co-Author: Rohini Morey, n/a – The University of Texas MD Anderson Cancer Center -
### @@@ Davis Ingram, n/a – MD Anderson Cancer Center ### 2452563###Co-Author######MD Anderson Cancer Center###
Co-Author: Davis Ingram, n/a – MD Anderson Cancer Center
### @@@ Khalida Wani, PhD – The University of Texas MD Anderson Cancer Center ### 2452801###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Khalida Wani, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Wei-lien Wang, MD – The University of Texas MD Anderson Cancer Center ### 2452419###Co-Author###Professor###The University of Texas MD Anderson Cancer Center###
Co-Author: Wei-lien Wang, MD – The University of Texas MD Anderson Cancer Center
### @@@ Jillian Losh, PhD – The University of Texas MD Anderson Cancer Center ### 2452954###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Jillian Losh, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Nadim Ajami, PhD – The University of Texas MD Anderson Cancer Center ### 2452955###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Nadim Ajami, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Jennifer Wargo, MD, MMSc – The University of Texas MD Anderson Cancer Center ### 2452956###Co-Author######The University of Texas MD Anderson Cancer Center###
Co-Author: Jennifer Wargo, MD, MMSc – The University of Texas MD Anderson Cancer Center
### @@@ Alexander Lazar, MD PhD – MD Anderson Cancer Center ### 2452571###Co-Author######MD Anderson Cancer Center###
Co-Author: Alexander Lazar, MD PhD – MD Anderson Cancer Center
### @@@ Christina Roland, MD, MS (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2452741###Co-Author###Associate Professor###The University of Texas MD Anderson Cancer Center###
Co-Author: Christina Roland, MD, MS (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Elise Nassif Haddad, MD – The University of Texas MD Anderson Cancer Center ### 2452797###Co-Author###Assistant Professor###The University of Texas MD Anderson Cancer Center###
Co-Author: Elise Nassif Haddad, MD – The University of Texas MD Anderson Cancer Center
### @@@ Emily Keung, MD – MD Anderson Cancer Center ### 2452740###Co-Author###Assistant Professor###MD Anderson Cancer Center###
Co-Author: Emily Keung, MD – MD Anderson Cancer Center
### Paper 07
SYSTEMATIC CHARACTERIZATION AND TARGETING OF MASTER REGULATOR DEPENDENCIES IN COEXISTING OSTEOSARCOMA SUBPOPULATIONS (Paper 05)
Favorite

Jovana Pavisic, MD, MA – Memorial Sloan Kettering Cancer Center ### 2453306###Author###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Author: Jovana Pavisic, MD, MA – Memorial Sloan Kettering Cancer Center
### @@@ Filemon S. Dela Cruz, MD (he/him/his) – Memorial Sloan Kettering Cancer Center ### 2452599###Co-Author###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Co-Author: Filemon S. Dela Cruz, MD (he/him/his) – Memorial Sloan Kettering Cancer Center
### he/him/his @@@ Somnath Tagore, PhD – Columbia University Irving Medical Center ### 2453307###Co-Author###Associate Research Scientist###Columbia University Irving Medical Center###
Co-Author: Somnath Tagore, PhD – Columbia University Irving Medical Center
### @@@ Pasquale Laise, PhD – Columbia University Irving Medical Center ### 2453308###Co-Author######Columbia University Irving Medical Center###
Co-Author: Pasquale Laise, PhD – Columbia University Irving Medical Center
### @@@ Daoqi You, n/a – Memorial Sloan Kettering Cancer Center ### 2452587###Co-Author######Memorial Sloan Kettering Cancer Center###
Co-Author: Daoqi You, n/a – Memorial Sloan Kettering Cancer Center
### @@@ Kristina Guillan, n/a – Memorial Sloan Kettering Cancer Center ### 2452586###Co-Author###Research Assistant###Memorial Sloan Kettering Cancer Center###
Co-Author: Kristina Guillan, n/a – Memorial Sloan Kettering Cancer Center
### @@@ Glorife Ibanez Sanchez, n/a – Memorial Sloan Kettering Cancer Center ### 2453309###Co-Author######Memorial Sloan Kettering Cancer Center###
Co-Author: Glorife Ibanez Sanchez, n/a – Memorial Sloan Kettering Cancer Center
### @@@ Adina Grunn, n/a – Columbia University Irving Medical Center ### 2453310###Co-Author######Columbia University Irving Medical Center###
Co-Author: Adina Grunn, n/a – Columbia University Irving Medical Center
### @@@ Samantha Brosius, MA – Memorial Sloan Kettering Cancer Center ### 2452582###Co-Author###Data Analyst###Memorial Sloan Kettering Cancer Center###
Co-Author: Samantha Brosius, MA – Memorial Sloan Kettering Cancer Center
### @@@ Leanne C. Sayles, BS – UCSF ### 2452583###Co-Author###Research Scientist###UCSF###
Co-Author: Leanne C. Sayles, BS – UCSF
### @@@ Alex Lee, PhD – UCSF ### 2453311###Co-Author######UCSF###
Co-Author: Alex Lee, PhD – UCSF
### @@@ Katherine A. Janeway, MD MMSc – Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School ### 2452449###Co-Author###Senior Physician###Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School###
Co-Author: Katherine A. Janeway, MD MMSc – Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School
### @@@ Darrell Yamashiro, MD, PhD – Columbia University Irving Medical Center ### 2453312###Co-Author###Professor of Pediatrics###Columbia University Irving Medical Center###
Co-Author: Darrell Yamashiro, MD, PhD – Columbia University Irving Medical Center
### @@@ Alejandro Sweet-Cordero, MD – UCSF ### 2452590###Co-Author###Professor Of Pediatrics###UCSF###
Co-Author: Alejandro Sweet-Cordero, MD – UCSF
### @@@ Julia Glade Bender, MD – Memorial Sloan Kettering Cancer Center ### 2453116###Co-Author###Attending###Memorial Sloan Kettering Cancer Center###
Co-Author: Julia Glade Bender, MD – Memorial Sloan Kettering Cancer Center
### @@@ Andrew Kung, MD, PhD – Memorial Sloan Kettering Cancer Center ### 2452598###Co-Author######Memorial Sloan Kettering Cancer Center###
Co-Author: Andrew Kung, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Andrea Califano, Dr. – Columbia University Irving Medical Center ### 2453313###Co-Author######Columbia University Irving Medical Center###
Co-Author: Andrea Califano, Dr. – Columbia University Irving Medical Center
### Paper 05